Wed. March 10, 2010
-
MarketWatch (press release)
March 9, 2010
ADNF drug candidate AL-309 is being developed for the treatment of peripheral neuropathies and is administered orally or subcutaneously. ...
Newswise (press release)
March 8, 2010
... myositis, antiphospholipid syndrome (APS), Sjogren's syndrome, uveitis, polymyositis, Raynaud's phenomenon, and demyelinating neuropathies.
Archives of Neurology
March 8, 2010
Peripheral neuropathies are a frequent complication of antineoplastic therapy. 2 Capecitabine is known to induce peripheral sensory neuropathy. ...
Healthcanal.com
March 5, 2010
... 3 patients' disease also impacts their central and peripheral nervous systems, in some cases causing vexing numbness, tingling and pain (neuropathies). ...
MarketWatch (press release)
March 5, 2010
ADNF drug candidate AL-309 is being developed for the treatment of peripheral neuropathies and is administered orally or subcutaneously. ...
Psychiatric Times
March 5, 2010
1-4 These disorders may cause symptoms that range from sensory neuropathies to severe psychiatric disturbances and involve the peripheral or central nervous ...
Market Wire (press release)
March 3, 2010
ADNF drug candidate AL-309 is being developed for the treatment of peripheral neuropathies and is administered orally or subcutaneously. ...
NorthJersey.com
March 3, 2010
One of the most common underlying causes of peripheral neuropathy is
diabetes. Symptoms can begin almost without notice. A numbness and/or tingling begins ...
MarketWatch (press release)
March 2, 2010
To date, our focus has been primarily on the assessment of neuropathies. neuropathies affect the peripheral nerves and parts of the spine and are frequently ...
Medscape
February 24, 2010
... muscle cramps are associated with a variety of neuropathic conditions, including amyotrophic lateral sclerosis (ALS) and peripheral neuropathies. ...
MarketWatch (press release)
February 24, 2010
EpiCept(TM) NP-1 - a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies, which affect more ...
Herald & Review
February 24, 2010
It is approved for the treatment of pain that often follows an outbreak of shingles, but it can be used for other neuropathies, too. ...
MarketWatch (press release)
February 23, 2010
AL-309 is being investigated as a treatment for peripheral neuropathy, a debilitating and painful disorder of the peripheral nervous system afflicting ...
Business Wire (press release)
February 22, 2010
... analgesic cream in late-stage clinical development designed to provide effective long-term relief of pain associated with peripheral neuropathies. ...
Massage Today
February 22, 2010
Common examples of peripheral neuropathies include carpal tunnel, thoracic outlet and piriformis syndromes. In a peripheral neuropathy, the nerve can be ...
Forbes (blog)
February 15, 2010
[who have] have experienced a variety of blast-related injuries including limb loss, soft-tissue damage, long-bone fractures, and peripheral neuropathies. ...
MarketWatch (press release)
February 10, 2010
To date, our focus has been primarily on the assessment of neuropathies. neuropathies affect the peripheral nerves and parts of the spine and are frequently ...
MarketWatch
February 5, 2010
... analgesic cream in late-stage clinical development designed to provide effective long-term relief of pain associated with peripheral neuropathies. ...
Leagle.com
February 5, 2010
The July 30, 2003 electromyogram showed evidence of median neuropathies at the wrists as seen in carpal tunnel syndrome, with a moderate degree of ...
MarketWatch
February 5, 2010
ADNF drug candidate AL-309 is being developed for the treatment of peripheral neuropathies and is administered orally or subcutaneously. ...
Benzinga
February 4, 2010
To date, our focus has been primarily on the assessment of neuropathies. neuropathies affect the peripheral nerves and parts of the spine and are frequently ...
Earthtimes (press release)
February 3, 2010
To date, our focus has been primarily on the assessment of neuropathies. neuropathies affect the peripheral nerves and parts of the spine and are frequently ...
istockAnalyst.com (press release)
February 2, 2010
... analgesic cream in late-stage clinical development designed to provide effective long-term relief of pain associated with peripheral neuropathies. ...
Huffington Post (blog)
February 1, 2010
In addition, we are seeing an increase in degenerative disorders such as arthritis,
neuropathies, peripheral vascular
diseases, and chronic inflammation in ...
pharmabiz.com
February 1, 2010
NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies. Orphan drug designation is ...
7thSpace Interactive (press release)
January 28, 2010
Here, we investigated in detail the immunopathology of this paretic syndrome and its possible resemblance to human neuropathies. ...
Market Wire (press release)
January 28, 2010
ADNF drug candidate AL-309 is being developed for the treatment of peripheral neuropathies and is administered orally or subcutaneously. ...
Blast
January 28, 2010
The people who have the brain lesions and the sever neuropathies. Our land would be worthless. Nobody would buy it. It's basically a nightmare. ...
Trading Markets (press release)
January 27, 2010
NP-1 is a prescription topical analgesic cream for long-term relief from the pain of peripheral
neuropathies. In
the USA, orphan status is granted to drugs ...
RTT News
January 26, 2010
NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies. It is a patented formulation ...
Earthtimes (press release)
January 26, 2010
NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies. Orphan drug designation is ...
Business Wire (press release)
January 25, 2010
... analgesic cream in late-stage clinical development designed to provide effective long-term relief of pain associated with peripheral neuropathies. ...
BioWorld Online
January 25, 2010
"Our goal with this trial was to unequivocally show that we don't have the neuropathies associated with the current standard of care," he said. ...
NHS Choices
January 25, 2010
The researchers emphasise the potential benefit of these findings for people with peripheral
neuropathies (nerve
diseases that can be caused by
diabetes or ...
Trading Markets (press release)
January 15, 2010
... topical analgesic cream in late-stage clinical development designed to provide effective long-term relief of pain associated with peripheral neuropathies.
PR-USA.net (press release)
January 14, 2010
ADNF drug candidate AL-309 is being developed for the treatment of peripheral neuropathies and is administered orally or subcutaneously. ...
Earthtimes (press release)
January 14, 2010
... analgesic cream in late-stage clinical development designed to provide effective long-term relief of pain associated with peripheral neuropathies. ...
TransWorldNews (press release)
January 13, 2010
... EpiCept NP-1 Cream (NP-1) is a prescription topical analgesic cream designed to provide relief of pain associated with peripheral neuropathies. ...
7thSpace Interactive (press release)
January 13, 2010
These were followed by the development of multiple cranial neuropathies, including seventh nerve palsy. Exhaustive further investigations yielded no ...
PR Newswire (press release)
January 12, 2010
The company's CNS
pipeline also includes CXB909, a small
molecule, orally active agent for the prevention and treatment of
neuropathies and ...
